SCHEMBL23578147

SCHEMBL23578147

COCCC1(OC)C(=O)N(C)c2cc(C(=O)OC)c(N)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.38
▸ ALDH1A1 P00352 7/20 0.36
▸ MAPT P10636 5/20 0.36
▸ GAA P10253 5/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ TSHR P16473 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GLA P06280 2/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ CASP7 P55210 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ ABL1 P00519 1/20 0.34
▸ CFTR P13569 3/20 0.33
▸ PKM P14618 2/20 0.32
▸ HTT P42858 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ KRAS P01116 1/20 0.30
▸ SOS1 Q07889 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30183870 1.00 KDM4E (0.38) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL23578082 0.87 KDM4E (0.40) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL23591311 0.85 GAA (0.41) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL23577862 0.84 SIRT6 (0.39) KDM4EALDH1A1MAPTPKMHTT
SCHEMBL30184061 0.84 SIRT6 (0.39) KDM4EALDH1A1MAPTPKMHTT
SCHEMBL23591297 0.79 ALDH1A1 (0.43) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL23577773 0.78 KDM4E (0.45) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL23590548 0.78 KDM4E (0.41) KDM4EALDH1A1MAPTGAAHSD17B10
SCHEMBL23591052 0.77 KDM4E (0.44) KDM4EALDH1A1MAPTGAAHSD17B10
Hydrochloric Acid SCHEMBL23578246 0.77 KDM4E (0.44) KDM4EALDH1A1MAPTGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081521-B1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LTD (IN) 2025-12-10 — — EP disclosed
CN-115605476-B Substituted tricyclic compounds 鲁宾有限公司 2024-05-24 — — CN disclosed
US-20230119316-A1 Substituted Tricyclic Compounds LUPIN LIMITED (IN) 2023-04-20 — — US disclosed
CN-115605476-A Substituted tricyclic compounds 鲁宾有限公司(IN) 2023-01-13 — — CN disclosed
EP-4081521-A1 SUBSTITUTED TRICYCLIC COMPOUNDS Lupin Limited (IN) 2022-11-02 — — EP disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed
WO-2021130731-A1 SUBSTITUTED TRICYCLIC COMPOUNDS LUPIN LIMITED (IN) 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230119316-A1 Substituted Tricyclic Compounds SOS1, RSU1, KSR1 KDM4E 4661/4885ALDH1A1 3322/4885MAPT 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback